3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase 1
2
Phase NA
1
Phase 4
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
5
Agnosia
4
Pain, Postoperative
3
Lung Neoplasms
3
Colonic Neoplasms
2
Cancer Pain
2
Acute Pain
2
Trigger Finger Disorder
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Skin Neoplasms
1
Rectal Neoplasms
1
Patient Satisfaction
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Opioid-Related Disorders
1
Neoplasms
1
Multiple Myeloma
1
Menorrhagia
1
Median Neuropathy
1
Leiomyoma
1
Ileus
1
Hemorrhage
1
Head and Neck Neoplasms
1
Goiter
1
Ganglion Cysts
1
Fever
1
Emergence Delirium
1
Diverticulosis, Colonic
1
Interventions
Dexamethasone
8
Oxycodone
6
Epoetin Alfa
5
Propofol
4
Palonosetron
4
Meropenem
4
Zoledronic Acid
3
Vancomycin
3
Sevoflurane
3
Ondansetron
3
Naloxone
3
Everolimus
3
Ciprofloxacin
3
Cholecalciferol
3
Ceftazidime
3
Cefepime
3
Calcium Dobesilate
3
Bevacizumab
3
Aspirin
3
Aprepitant
3
peginterferon alfa-2a
2
edoxaban
2
apixaban
2
apatinib
2
Vitamin B 12
2
Vincristine
2
Tobacco Use Cessation Devices
2
Teicoplanin
2
Tablets
2
Surgical Procedures, Operative
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neoplasms
×
Acetaminophen
×
Clear all
NCT01070732
2010-02-18
APOTEL01
University of Athens
Phase 4
Completed
100 enrolled